Article metrics

Download PDFPDF

#1121 KEYNOTE-826: final overall survival results from a randomized, double-blind, phase 3 study of pembrolizumab + chemotherapy vs placebo + chemotherapy for first-line treatment of persistent, recurrent, or metastatic cervical cancer
Free

 

Online download statistics by month:

Online download statistics by month: September 2023 to November 2024

AbstractFullPdf
Sep 20232803
Oct 2023131012
Nov 2023105016
Dec 20234906
Jan 20244308
Feb 20244206
Mar 202449012
Apr 20242409
May 20245109
Jun 20243307
Jul 20242309
Aug 20247909
Sep 202483011
Oct 202474012
Nov 20244609
Total8600138